ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

No Cancer Letter For Two Weeks

August 10, 1990

NIH Carcinogen Guidelines Offered

April 24, 1981

Mammography Flap Heats Up Again RP Statistician Says New Rules Worse Than Old

December 10, 1976

In Brief: Three Scientists Share Nobel Prize For Work In Genetics; Clinton Forms Bioethics Panel

October 13, 1995

Researchers Link Obesity With 34% Higher Death Risk In Pre-Menopausal Women

May 30, 2014